Back
Keros Therapeutics Stock Price Chart
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35
KROS
Keros Therapeutics
Last Price:
55.82
Seasonality Move:
37.33%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is moderately bullish and KROS is experiencing slight buying pressure.
Keros Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.81 | Buy |
| 20-day SMA: | 51.2 | Buy |
| 50-day SMA: | 49.36 | Buy |
| 200-day SMA: | 52.15 | Buy |
| 8-day EMA: | 55.34 | Buy |
| 20-day EMA: | 52.61 | Buy |
| 50-day EMA: | 50.31 | Buy |
| 200-day EMA: | 49.54 | Buy |
Keros Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.54 | Buy |
| Relative Strength Index (14 RSI): | 69.78 | Buy |
| Chaikin Money Flow: | 11894 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.63 - 54.93) | Buy |
| Bollinger Bands (100): | (44.93 - 54.13) | Buy |
Keros Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Keros Therapeutics Stock
Is Keros Therapeutics Stock a Buy?
- Keros Therapeutics share price is 57.32 while KROS 8-day simple moving average is 55.81, which is a Buy signal.
- The stock price of KROS is 57.32 while Keros Therapeutics 20-day SMA is 51.20, which makes it a Buy.
- Keros Therapeutics 50-day simple moving average is 49.36 while KROS share price is 57.32, making it a Buy technically.
- KROS stock price is 57.32 and Keros Therapeutics 200-day simple moving average is 52.15, creating a Buy signal.
KROS Technical Analysis vs Fundamental Analysis
Sell
35
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy or a Sell?
-
Keros Therapeutics stock is rated a Sell
The current Keros Therapeutics [KROS] share price is $57.32. The Score for KROS is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Keros Therapeutics Stock Info
Market Cap:
2.15B
Price in USD:
57.32
Share Volume:
361.39K
Keros Therapeutics 52-Week Range
52-Week High:
73.00
52-Week Low:
27.02
Sell
35
Keros Therapeutics (KROS)
is a Sell
Keros Therapeutics Share Price Forecast
-
What is the Keros Therapeutics stock price today?
The Keros Therapeutics stock price is 57.32 USD today. -
Will KROS stock go up or go down?
Keros Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Keros Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Keros Therapeutics is overvalued.
Is Keros Therapeutics Stock a Buy?
- Keros Therapeutics share price is 57.32 while KROS 8-day exponential moving average is 55.34, which is a Buy signal.
- The stock price of KROS is 57.32 while Keros Therapeutics 20-day EMA is 52.61, which makes it a Buy.
- Keros Therapeutics 50-day exponential moving average is 50.31 while KROS share price is 57.32, making it a Buy technically.
- KROS stock price is 57.32 and Keros Therapeutics 200-day simple moving average is 49.54, creating a Buy signal.
Fundamental Analysis of Keros Therapeutics
Is Keros Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.31 per share, and a decrease next year of $0.43 per share.
Technical Analysis of Keros Therapeutics
Should I short Keros Therapeutics stock?
- KROS Moving Average Covergence Divergence (MACD) indicator is 2.54, suggesting Keros Therapeutics is a Buy
- Keros Therapeutics Relative Strength Index (RSI) is 69.78, which suggest Keros Therapeutics is overbought
- The Bollinger Bands (25) for Keros Therapeutics is (45.63 - 54.93), which suggest Keros Therapeutics is a Buy
- The Bollinger Bands (100) for Keros Therapeutics is (44.93 - 54.13), which suggest Keros Therapeutics is a Buy
* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.